Effects of propylthiouracil and methimazole on fetal thyroid status in mothers with Graves' hyperthyroidism

Journal of Clinical Endocrinology and Metabolism

Volumn 82, Issue 11, 1997, Pages 3633-3636

  Momotani, Naoko ^a   Noh, Jaeduk Yoshimura ^a   Ishikawa, Naofumi ^a   Ito, Kunihiko ^a  

^a ITO HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PROPYLTHIOURACIL; THIAMAZOLE; THYROTROPIN; THYROXINE;

ADULT; ARTICLE; CLINICAL TRIAL; DOSE RESPONSE; DRUG EFFECT; FEMALE; FETUS; FREE THYROXINE INDEX; GRAVES DISEASE; HUMAN; HYPOTHYROIDISM; MAJOR CLINICAL STUDY; MOTHER FETUS RELATIONSHIP; PRIORITY JOURNAL; THYROID FUNCTION TEST;

EID: 0030694394     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.82.11.4347     Document Type: Article

References (27)

1. Dussault JH. 1993 Neonatal screening for congenital hypothyroidism. Clin Lab Med. 13:645-652.
2. Marchant B, Brownlie BEW, Hart DM, Horton PW, Alexander WD. 1977 The placental transfer of propylthiouracil, methimazole and carbimazole. J Clin Endocrinol Metab. 45:1187-1193.
3. Gardner DF, Cruikshank DP, Hays PM, Cooper DS. 1986 Pharmacology of propylthiouracil (PTU) in pregnant hyperthyroid women: correlation of maternal PTU concentrations with cord serum thyroid function tests. J Clin Endocrinol Metab. 62:217-220.
4. Cooper DS. 1991 Treatment of thyrotoxicosis. In: Braverman LE, Utiger RD, eds. Werner and Ingbar's the thyroid: a fundamental and clinical text, 6th ed. Philadelphia: Lippincott; 887-916.
5. Davis LE, Lucas MJ, Hankins GDV, Roark ML, RN, Cunningham FG. 1989 Thyrotoxicosis complicating pregnancy. Am J Obstet Gynecol. 160:63-70.
6. Momotani N, Yamashita R, Yoshimoto M, Noh J, Ishikawa N, Ito K. 1989 Recovery from foetal hypothyroidism: evidence for the safety of breast-feeding while taking propylthiouracil. Clin Endocrinol (Oxf). 31:591-595.
7. Shewring G, Smith BR. 1982 An improved radioreceptor assay for TSH receptor antibodies. Clin Enciocrinol (Oxf). 17:409-417.
8. Momotani N, Noh J, Oyanagi H, Ishikawa N, Ito K. 1986 Antithyroid drug therapy for Graves' disease during pregnancy. N Engl J Med. 315:24-28.
9. Kampmann JP, Hansen JEM. 1983 Serum protein binding of propylthiouracil. Br J Clin Pharmacol. 16:549-552.
10. Cooper DS, Bode HH, Nath B, Saxe V, Maloof F, Ridgway EC. 1984 Methimazole pharmacology in man: studies using a newly developed radioimmunoassay for methimazole. J Clin Endocrinol Metab. 58:473-479.
11. Mortimer RH, Tyack SA, Galligan JP, Perry-Keene DA, Tan YM. 1990 Graves' disease in pregnancy: TSH receptor binding inhibiting immunoglobulins and maternal and neonatal thyroid function. Clin Endocrinol (Oxf). 32:141-152.
12. Cheron RG, Kaplan MM, Larsen PR, Selenkow HA, Crigler Jr JF. 1981 Neonatal thyroid function after propylthiouracil therapy for maternal Graves' disease. N Engl J Med. 304:525-528.
13. Refetoff S, Ochi Y, Selenkow HA, Rosenfield RL. 1974 Neonatal hypothyroidism and goiter in one infant of each of two sets of twins due to maternal therapy with antithyroid drugs. J Pediatr. 85:240-244.
14. Simons WF, Fuggle PW, Grant DB, Smith I. 1994 Intellectual development at 10 years in early treated congenital hypothyroidism. Arch Dis Child. 71:232-234.
15. Dubuis J-M, Glorieux J, Richer F, Deal CL, Dussault JH, Vliet GV. 1996 Outcome of severe congenital hypothyroidism: closing the developmental gap with early high dose levothyroxine treatment. J Clin Endocrinol Metab. 81:222-227.
16. McCarroll AM, Hutchinson M, McAuley R, Montgomery DAD. 1976 Long-term assessment of children exposed in vitro to carbimazole. Arch Dis Child. 51:532-536.
17. Burrow GN, Klatskin EH, Genel M. 1978 Intellectual development in children whose mothers received propylthiouracil during pregnancy. Yale J Biol Med. 51:151-156.
18. Messer PM, Hauffa BP, Olbricht T, Benker G, Kotulla P, Reinwein D. 1990 Antithyroid drug treatment of Graves' disease in pregnancy: long-term effects on somatic growth, intellectual development and thyroid function of the off-spring. Acta Endocrinol (Copenh). 123:311-316.
19. Eisenstein Z, Weiss M, Katz Y, Bank H. 1992 Intellectual capacity of subjects exposed to methimazole or propylthiouracil in utero. Eur J Pediatr. 151:558-559.
20. Burrow GN. 1975 The thyroid in pregnancy. Med Clin North Am. 59:1089-1098.
21. Mandel SJ, Brent GA, Larsen PR. 1994 Review of antithyroid drug use during pregnancy and report of a case of aplasia cutis. Thyroid. 4:129-133.
22. Momotani N, Ito K, Hamada N, Ban Y, Nishikawa Y, Mimura T. 1984 Maternal hyperthyroidism and congenital malformation in the offspring. Clin Endocrinol (Oxf). 20:695-700.
23. Van Dijke CP, Heydendael RJ, De Kleine MJ. 1987 Methimazole, carbimazole, and congenital skin defects. Ann Intern Med. 106:60-61.
24. Cooper DS. 1984 Antithyroid drugs. N Engl J Med. 311:1353-1362.
25. Cooper DS. 1985 Propylthiouracil levels in hyperthyroid patients unresponsive to large doses. Ann Intern Med. 102:328-331.
26. Okamura K, Ikenoue H, Shiroozu A, Sato K, Yoshinari M, Fujishima M. 1987 Reevaluation of the effects of methylmercaptoimidazole and propylthiouracil in patients with Graves' hyperthyroidism. J Clin Endocrinol Metab. 65:719-723.
27. Wing DA, Millar LK, Koonings PP, Montoro MN, Mestman JH. 1994 A comparison of propylthiouracil versus methimazole in the treatment of hyperthyroidism in pregnancy. Am J Obstet Gynecol. 170:90-95.